Proteomics reliability for micropollutants degradation insight into activated sludge systems

Area of Science:

• Environmental Science
• Microbiology
• Analytical Chemistry

Background:

• Limited understanding exists regarding the degradation pathways of pharmaceutical trace compounds in wastewater.
• Ibuprofen, a widely used pharmaceutical, is frequently detected in wastewater and environmental compartments despite high removal rates.
• Activated sludge is a key component in wastewater treatment for removing contaminants.

Purpose of the Study:

• To evaluate the utility of proteomics for investigating microbial metabolism in activated sludge during ibuprofen degradation.
• To analyze protein profile variations in activated sludge exposed to ibuprofen at different concentrations.
• To identify specific proteins that change in response to ibuprofen exposure.

Main Methods:

• Activated sludge batch tests were conducted with ibuprofen spiked at 10 and 1,000 μg L(-1).
• Ibuprofen concentrations were measured in the liquid phase to determine removal rates and kinetics.
• Proteomics analysis was performed on the solid phase (activated sludge) to assess protein expression and changes.

Main Results:

• Complete removal of ibuprofen from the liquid phase was observed, with kinetics estimated.
• No novel proteins were newly expressed in the activated sludge.
• Proteomics analysis successfully identified 62 proteins showing plausible trends in presence and intensity changes related to ibuprofen exposure.

Conclusions:

• Proteomics is a promising methodology for studying microbial responses to pharmaceutical compounds in wastewater treatment.
• The study provided valuable data on biological reproducibility and protein behavior under pharmaceutical stress.
• The findings contribute to understanding the microbial processes involved in the biodegradation of pharmaceuticals like ibuprofen.